Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
NovoCure Ltd (NASDAQ: NVCR) closed the day trading at $26.35 up 0.46% from the previous closing price of $26.23. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.89 million shares were traded. NVCR stock price reached its highest trading level at $27.7 during the session, while it also had its lowest trading level at $26.325.
Ratios:
For a better understanding of NVCR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.44 and its Current Ratio is at 1.49. In the meantime, Its Debt-to-Equity ratio is 1.87 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 02, 2024, Upgraded its rating to Outperform and sets its target price to $30 from $18 previously.
On October 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $24 to $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 11 ’25 when Paravasthu Mukund sold 2,160 shares for $26.81 per share. The transaction valued at 57,906 led to the insider holds 31,437 shares of the business.
MUKUND PARAVASTHU bought 2,160 shares of NVCR for $57,788 on Jan 13 ’25. On Jan 02 ’25, another insider, WILHELMUS C. GROENHUYSEN, who serves as the Officer of the company, bought 266,085 shares for $29.80 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 2851096320 and an Enterprise Value of 2566835712. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.93 while its Price-to-Book (P/B) ratio in mrq is 7.90. Its current Enterprise Value per Revenue stands at 4.443 whereas that against EBITDA is -18.255.
Stock Price History:
The Beta on a monthly basis for NVCR is 0.65, which has changed by 0.80896556 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $11.70. The 50-Day Moving Average of the stock is 6.06%, while the 200-Day Moving Average is calculated to be 35.89%.
Shares Statistics:
Over the past 3-months, NVCR traded about 1.39M shares per day on average, while over the past 10 days, NVCR traded about 1053360 shares per day. A total of 108.10M shares are outstanding, with a floating share count of 96.88M. Insiders hold about 10.47% of the company’s shares, while institutions hold 85.92% stake in the company. Shares short for NVCR as of 1735603200 were 5396504 with a Short Ratio of 3.88, compared to 1732838400 on 5633356. Therefore, it implies a Short% of Shares Outstanding of 5396504 and a Short% of Float of 5.96.
